OCT

Three Questions: Irina Petrova, M.D., OCT

Monday, December 12, 2016

CWWeekly presents this feature as a spotlight on issues faced by executives in clinical research. This week, writer Karyn Korieth spoke with Irina Petrova, M.D., director of Clinical Operations at OCT, a full-service CRO based in Russia that also operates in Europe and the U.S.

[Read More]

Benefits for international multicenter clinical trials in Russia

Thursday, September 1, 2016

In the last 20 years, Russia has seen an increasing growth of the clinical trials industry. Among the factors contributing to that are top-grade research facilities, vast and easy-to-access populations and low participation costs. Over the past two years, significant changes have occurred in this market that are likely to have a global impact. All recent legislative efforts were aimed at harmonizing the local regulatory requirements with international standards and pharmacovigilance procedures. Clinical trials in Russia undergo regular FDA inspections and are among one of the world’s best in terms of quality, exceeding Western countries.

[Read More]

Guest Commentary: Setting Up Successful Investigator Meetings in Eastern Europe

Tuesday, December 16, 2008

According to the August issue of The Centerwatch Monthly, the number of investigators in Central and Eastern Europe who filed Form FDA 1572s last year was close to 3,000, which means investigator participation in global clinical trials conducted in the region was up 25% over the prior year’s. Sponsors and global project managers from Western countries are managing teams and investigators from this region, and it is important for them to understand the specifics of this process.

[Read More]